Search Results 821-830 of 18150 for multiple%20sclerosis
Dalfampridine is used to help improve walking in patients with multiple sclerosis. This medicine is a potassium channel blocker. This medicine is available ...
Collaborators · Alzheimer's Disease Research Center · Center for Multiple Sclerosis and Autoimmune Neurology · Mayo Clinic Study of Aging · Motion Analysis: Kenton ...
Multiple myeloma care at Mayo Clinic · Request an appointment · Diagnosis & treatmentCare at Mayo Clinic. Dec. 20, 2024. Print. Living with multiple myeloma?
A Study to Evaluate Sex and Gender in Multiple System Atrophy ... Multiple System Atrophy (MSA) in order to ... Sclerosis (ALS). A Study to Develop A Family ...
Claims that thiamine is effective for treatment of skin problems, chronic diarrhea, tiredness, mental problems, multiple sclerosis ... two different medicines may ...
The primary objective of this observational study is to identify the molecular profiles and clinical characteristics that define subsets of myeloma patients ...
We expect to have 1-year follow-up examinations on at least 120 NAFLD patients assuming a 20% withdraw rate. Participation eligibility. Participant ...
Mayo Clinic researchers demonstrate nearly 20% boost in adolescent HPV vaccination rates using comprehensive strategy ... multiple types of skin. Cancer. Mayo ...
Adult Still disease · Alzheimer's disease · Amyotrophic lateral sclerosis (ALS) ... Multiple sclerosis · Multiple system atrophy ... 20, 2024. Share on: Facebook ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.